Garnier names Tina Fey as new skin care spokeswoman
NEW YORK — Garnier USA, a subsidiary of L’Oréal USA, has named Tina Fey as the new spokeswoman for Garnier skin care. Fey, who has been the face of Garnier Nutrisse hair color since 2011, now expands her relationship with Garnier in a new advertising campaign launching in April.
Fey’s endorsement will span the entire Garnier Ultra-Lift skin care line, including moisturizers, serums and eye products. The campaign will focus on a line of new anti-aging products, including Ultra-Lift Transformer, an anti-age skin corrector that fights wrinkles while restoring firmness, and Ultra-Lift Anti-Wrinkle Firming Night Cream, a natural, pro-retinol formula that continues the battle against aging as you sleep.
"Tina Fey has been an enormous success for us," stated David Greenberg, president of Maybelline New York, Garnier and essie. "Tina’s personality, beauty and approachability resonate with our consumer and we are thrilled to keep her in the Garnier family."
The campaign debuts to consumers in April, with the launch of national TV and print advertising across major media outlets.
Akorn completes acquisition of Hi-Tech Pharmacal
LAKE FOREST, Ill. — Akorn on Thursday announced that it has completed its previously announced acquisition of Hi-Tech Pharmacal for $640 million in cash. The combination of Akorn and Hi-Tech will transform the company into a larger, more diversified generic player, the company stated. This combination also brings critical mass and scale to Akorn’s business and strengthens the company’s position with retail and institutional customers.
In addition, the acquisition expands manufacturing capabilities into additional niche dosage forms including nasal sprays, topical gels, creams, ointments and oral liquids, Akorn noted, and it provides additional breadth in the retail OTC market.
“We welcome our new colleagues from the Hi-Tech team and look forward to collaborating with them on the future direction of our company," stated Raj Rai, Akorn CEO. "Our priority now turns to executing on our integration plan."
Ad Age: Reckitt Benckiser seeking new creative to drive Mucinex business
NEW YORK — Reckitt Benckiser is seeking new creative behind its Mucinex brand, according to a report published in Ad Age Thursday.
Citing Kantar data, Ad Age reported RB placed $92 million behind Mucinex in 2012, when there was a strong and robust cough, cold and flu season helping to drive sales. Spending behind Mucinex in 2013 fell to $57 million.
RB CEO Rakesh Kapoor told analysts Wednesday that RB is "creating a new force in consumer health."
"We are allocating significant resources to consumer health, in terms of capabilities, R&D, brand equity investment and innovation, and we are seeing strong organic growth," he said. RB recently introduced Mucinex Allergy to store shelves.